Hodgkin's disease: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
mNo edit summary |
||
| Line 20: | Line 20: | ||
In the classical variant, giant usually multinucleate Hodgkin's and [[Reed-Sternberg cells]], the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. | In the classical variant, giant usually multinucleate Hodgkin's and [[Reed-Sternberg cells]], the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}}[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 17:00, 28 August 2024
Also called Hodgkin disease and Hodgkin's lymphoma, Hodgkin's disease is a malignant, but potentially curable, disease of the lymph nodes, spleen, and general lymphoid tissue.
Five variants are defined by the World Health Organization, grouped into two classes:[1]
- Classical
- nodular sclerosis
- mixed cellularity
- lymphocyte depleted
- lymphocyte rich
- nodular lymphocyte predominant Hodgkin disease (NLPHD).
Classical and NLHPD are different clinical entities.[2]
In the classical variant, giant usually multinucleate Hodgkin's and Reed-Sternberg cells, the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
References
- ↑ Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
- ↑ Scott K Dessain, James L Spears, Athanassios Argiris (22 December 2009), "Hodgkin Disease: Overview", eMedicine